Review Article
Thermosensitive block copolymer hydrogels based on poly(ɛ-caprolactone) and polyethylene glycol for biomedical applications: State of the art and future perspectives
Monica Boffito,
Paolo Sirianni,
Anna Maria Di Rienzo,
Valeria Chiono,
Monica Boffito
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Search for more papers by this authorPaolo Sirianni
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Search for more papers by this authorAnna Maria Di Rienzo
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Search for more papers by this authorCorresponding Author
Valeria Chiono
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Correspondence to: V. Chiono; e-mail: [email protected]Search for more papers by this authorMonica Boffito,
Paolo Sirianni,
Anna Maria Di Rienzo,
Valeria Chiono,
Monica Boffito
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Search for more papers by this authorPaolo Sirianni
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Search for more papers by this authorAnna Maria Di Rienzo
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Search for more papers by this authorCorresponding Author
Valeria Chiono
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, Turin, Italy
Correspondence to: V. Chiono; e-mail: [email protected]Search for more papers by this authorAbstract
This review focuses on the challenges associated with the design and development of injectable hydrogels of synthetic origin based on FDA approved blocks, such as polyethylene glycol (PEG) and poly(ɛ-caprolactone) (PCL). An overview of recent studies on inverse thermosensitive PEG/PCL hydrogels is provided. These systems have been proposed to overcome the limitations of previously introduced degradable thermosensitive hydrogels [e.g., PEG/poly(lactide-co-glycolic acid) hydrogels]. PEG/PCL hydrogels are advantageous due to their higher gel strength, slower degradation rate and availability in powder form. Particularly, triblock PEG/PCL copolymers have been widely investigated, with PCL–PEG–PCL (PCEC) hydrogels showing superior gel strength and slower degradation kinetics than PEG–PCL–PEG (PECE) hydrogels. Compared to triblock PEG/PCL copolymers, concentrated solutions of multiblock PEG/PCL copolymers were stable due to their slower crystallization rate. However, the resulting hydrogel gel strength was low. Inverse thermosensitive triblock PEG/PCL hydrogels have been mainly applied in tissue engineering, to decrease tissue adherence or, in combination with bioactive molecules, to promote tissue regeneration. They have also found application as in situ drug delivery carriers. On the other hand, the wide potentialities of multiblock PEG/PCL hydrogels, associated with the stability of their water-based solutions under storage, their higher degradation time compared to triblock copolymer hydrogels and the possibility to insert bioactive building blocks along the copolymer chains, have not been fully exploited yet. A critical discussion is provided to highlight advantages and limitations of currently developed themosensitive PEG/PCL hydrogels, suggesting future strategies for the realization of PEG/PCL-based copolymers with improved performance in the different application fields. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1276–1290, 2015.
REFERENCES
- 1 Ruel-Garièpy E, Leroux J-C. In situ-forming hydrogels-review of temperature sensitive systems. Eur J Pharm Biopharm 2004; 58: 409–426.
- 2 Nguyen MK, Lee DS. Injectable biodegradable hydrogels. Macromol Biosci 2010; 10: 563–579.
- 3 Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications—A review. Eur J Pharm Biopharm 2008; 68: 34–45.
- 4 Ward MA, Georgiou TK. Thermoresponsive polymers for biomedical applications. Polymers 2011; 3: 1215–1242.
- 5 Kabanov AV, Alakhov VY. Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst 2002; 19: 1–72.
- 6 Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006; 23: 2709–2728.
- 7 Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997; 388: 860–862.
- 8 Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010; 31: 3997–4008.
- 9 Ding T, Sun J, Zhang P. Study on MCP-1 related to inflammation induced by biomaterials. Biomed Mater 2009; 4: 035005.
- 10 Kim MS, Ahn HH, Cho MH, Shin YN, Khang G, Lee HB. An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosa based scaffolds. Biomaterials 2007; 28: 5137–5143.
- 11 Pratoomsoot C, Tanioka H, Hori K, Kawasaki S, Kinoshita S, Tighe PJ, Duad H, Shakesheffa KM, Rose FRAJ. A thermoreversible hydrogel as a biosynthetic bandage for corneal wound repair. Biomaterials 29;2008: 272–281.
- 12 Tarasevich BJ, Gutowska A, Li XS, Jeong BM. The effect of polymer composition on the gelation behavior of PLGA-g-PEG biodegradable thermoreversible gels. J Biomed Mater Res A 2009; 89: 248–254.
- 13 Lin G, Cosimbescu L, Karin NJ, Tarasevich BJ. Injectable and thermosensitive PLGA-g-PEG hydrogels containing hydroxyapatite: Preparation, characterization and in vitro release behavior. Biomed Mater 2012; 7: 024107.
- 14 Bonacucina G, Cespi M, Mencarelli G, Giorgioni G, Palmieri GF. Thermosensitive self-assembling block copolymers as drug delivery systems. Polymers 2011; 3: 779–811.
- 15 Bae SJ, Joo MK, Jeong Y, Kim SW, Lee W-K, Sohn YS, Jeong B. Gelation behavior of poly(ethylene glycol) and polycaprolactone triblock and multiblock copolymer aqueous solutions. Macromolecules 2006; 39: 4873–4879.
- 16 Zhu GZ, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Biotechnology 2000; 18: 52–57.
- 17 Wei XW, Gong CY, Gou ML, Fu SZ, Guo QF, Shi S, Luo F, Guo G, Qiu LY, Qian ZY. Biodegradable poly(ɛ-caprolactone)–poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm 2009; 381: 1–18.
- 18 Wang C, Li H, Zhao X. Ring opening polymerization of l-lactide initiated by creatinine. Biomaterials 2004; 25: 5797–5801.
- 19 Shin ILG, Kim SY, Lee YM, Cho CS, Sung YK. Methoxy poly(ethylene glycol)/ɛ-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J Control Release 1998; 51: 1–11.
- 20 Gong CY, Shi S, Wu L, Gou ML, Yin QQ, Guo QF, Dong PW, Zhang F, Luo F, Zhao X, Wei YQ, Qian ZY. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL–PEG–PCL hydrogel. Part 2: Sol–gel–sol transition and drug delivery behavior. Acta Biomater 2009; 5: 3358–3370.
- 21 Ma G, Miao B, Song C. Thermosensitive PCL–PEG–PCL hydrogels: Synthesis, characterization, and delivery of proteins. J Appl Polym Sci 2010; 116: 1985–1993.
- 22 Huang MJ, Gou ML, Qian ZY, Dai M, Li XY, Cao M, Wang K, Zhao J, Yang JL, Lu Y, Tu MJ, Wei YQ. One-step preparation of poly(epsilon-caprolactone)–poly(ethylene glycol)–poly(epsilon-caprolactone) nanoparticles for plasmid DNA delivery. J Biomed Mater Res A 2008; 86A: 979–986.
- 23 Gong CY, Qian ZY, Liu CB, Huang MJ, Gu YC, Wen YJ, Kan B, Wang K, Dai M, Li XY, Gou ML, Tu MJ, Wei YQ. A thermosensitive hydrogel based on biodegradable amphiphilic poly(ethylene glycol)–polycaprolactone poly(ethylene glycol) block copolymers. Smart Mater Struct 2007; 16: 927–933.
- 24 Gong CY, Dong PW, Shi S, Fu SZ, Yang JL, Guo G, Zhao X, Wei YQ, Qian ZY. Thermosensitive PEG–PCL–PEG hydrogel controlled drug delivery system: Sol–gel–sol transition and in vitro drug release study. J Pharm Sci 2009; 98: 3707–3717.
- 25
Lamda NMK,
Woodhouse KA,
Cooper SL. Polyurethanes in Biomedical Applications. Boca Raton: CRC Press; 1998.
10.2466/PR0.83.7.930-930 Google Scholar
- 26 Petrova T, Manolova N, Rashkov I, Li S, Vert M. Synthesis and characterization of poly(oxyethylene)–poly(caprolactone) multiblock copolymers. Polymer Int 1998; 45: 419–926.
- 27 Li S, Garreau H, Vert M, Petrova T, Manolova N, Rashkov I. Hydrolytic degradation of poly(oxyethylene)–poly(ɛ-caprolactone) multiblock copolymers. J Appl Polym Sci 1998; 68: 989–998.
- 28 Lee JW, Hua F, Lee DS. Thermoreversible gelation of biodegradable poly(ɛ-caprolactone) and poly(ethylene glycol) multiblock copolymers in aqueous solutions. J Control Release 2001; 73: 315–327.
- 29 Zhang Y, Zhuo R. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly(ethylene glycol) and polycaprolactone. Biomaterials 2005; 26: 6736–6742.
- 30 Loh XJ, Sng KBC, Li K. Synthesis and water-swelling of thermo-responsive poly(ester urethane)s containing poly(3-caprolactone), poly(ethylene glycol) and poly(propylene glycol). Biomaterials 2008; 29: 3185–3194.
- 31 Hwang MJ, Suh JM Bae YH, Kim SW, Jeong B. Caprolactonic poloxamer analog: PEG–PCL–PEG. Biomacromolecules 2005; 6: 885–890.
- 32 Gong CY, Shi S, Dong PW, Kan B, Gou ML, Wang XH, Li XY, Luo F, Zhao X, Wei YQ, Qiana ZY. Synthesis and characterization of PEG–PCL–PEG thermosensitive hydrogel. Int J Pharm 2009; 365: 89–99.
- 33 Ferruti P, Mancin I, Ranucc E, Felice CD, Latin G, Laus M. Polycaprolactone–poly(ethylene glycol) multiblock copolymers as potential substitutes for di(ethylhexyl) phthalate in flexible poly(vinyl chloride) formulations. Biomacromolecules 2003; 4: 181–188.
- 34 Kim IY, Yoo MK, Kim BC, Park IY, Lee HC, Cho CS. Thermogelling behaviors of poly(caprolactone-b-ethylene glycol-b-caprolactone) triblock copolymer in the presence of hyaluronic acid. J Polym Sci A 2008; 46: 3629–3637.
- 35 Payyappilly S, Dhara S, Chattopadhyay S. Thermoresponsive biodegradable PEG–PCL–PEG based injectable hydrogel for pulsatile insulin delivery. Mater Res Part A 2013; 102: 1500–1509 doi:10.1002/jbm.a.34800.
- 36
Raghavan SR,
Cipriano BH. Gel formation: Phase diagrams using tabletop, rheology and calorimetry. In: P Terech, RG Weiss, editors. Molecular Gels: Materials With Self-Assembled Fibrillar Networks. Dordrecht, The Netherlands: Springer; 2006. p 241–252.
10.1007/1-4020-3689-2_9 Google Scholar
- 37 Jeong B, Kim SW, Bae YH. Thermosensitive sol–gel reversible hydrogels. Adv Drug Deliv Rev 2002; 54: 37–51.
- 38 Gong CY, Shi S, Dong PW, Yang B, Qi XR, Guo G, Gu YC, Zhao X, Wei YQ, Qian ZY. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL–PEG–PCL hydrogel: Part 1—Synthesis, characterization, and acute toxicity evaluation. J Pharm Sci 2009; 98: 4684–4694.
- 39 Jiang Z, Hao J, You Y, Liu Y, Wang Z, Deng X. Biodegradable and thermoreversible hydrogels of poly(ethylene glycol)–poly(epsilon-caprolactone-co-glycolide)–poly(ethylene glycol) aqueous solutions. J Biomed Mater Res Part A 2008; 87A: 45–51.
- 40 Mishra GP, Tamboli V, Mitra AK. Effect of hydrophobic and hydrophilic additives on sol–gel transition and release behavior of timolol maleate from polycaprolactone-based hydrogel. Colloid Polym Sci 2011; 289: 1553–1562.
- 41 Lin G, Cosimbescu L, Karin NJ, Gutowska A, Tarasevich BJ. Injectable and thermogelling hydrogels of PCL-g-PEG: Mechanisms, rheological and enzymatic degradation properties. J Mater Chem B 2013; 1: 1249–1255.
- 42 Chassenieux C, Nicolai T, Benyahia L. Rheology of associative polymer solutions. Curr Opin Colloid In 2011; 16: 18–26.
- 43 Bae SJ, Suh JM, Sohn YS, Bae YH, Kim SW, Jeong B. Thermogelling poly(caprolactone-b-ethylene glycol-b-caprolactone) aqueous solutions. Macromolecules 2005; 38: 5260–5265.
- 44 Li ZQ, Guo XL, Guan JJ. A thermosensitive hydrogel capable of releasing bFGF for enhanced differentiation of mesenchymal stem cell into cardiomyocyte-like cells under ischemic conditions. Biomacromolecules 2012; 13: 1956–1964.
- 45 Macaya D, Spector M. Injectable hydrogel materials for spinal cord re generation: A review. Biomed Mater 2012; 7: 012001.
- 46 Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science 2009; 324: 1673–1677.
- 47 Bertz A, Wöhl-Bruhn S, Miethe S, Tiersch B, Koetz J, Hust M, Bunjes H, Menzel H. Encapsulation of proteins in hydrogel carrier systems for controlled drug delivery: Influence of network structure and drug size on release rate. J Biotechnol 2013; 163: 243–249.
- 48 Canal T, Peppas NA. Correlation between mesh size and equilibrium degree of swelling of polymeric networks. J Biomed Mater Res A 1989; 23: 1183–1193.
- 49 Mourya VK, Inamdar N, Nawale RB, Kulthe SS. Polymeric micelles: General considerations and their applications. Int J Pharm Edu Res 2011; 45: 128–138.
- 50 Jeong B, Choi YK, Bae YH, Zentner G, Kim SW. New biodegradable polymers for injectable drug delivery systems. J Control Release 1999; 62: 109–114.
- 51 Israelachvili JN. Intermolecular and Surface Forces, Revised 3rd ed. Burlington, MA: Academic Press; 2011.
- 52 Kwon KW, Park MJ, Bae YH, Kim HD, Char K. Gelation behavior of PEO–PLGA–PEO triblock copolymers in water. Polymer 2002; 43: 3353–3358.
- 53 Loh XJ, Goh SH, Li J. New biodegradable thermogelling copolymers having very low gelation concentrations. Biomacromolecules 2007; 8: 585–593.
- 54 Hoare TR, Kohane DS. Hydrogels in drug delivery: Progress and challenges. Polymer 2008; 49: 1993–2007.
- 55 Göpferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996; 17: 103–114.
- 56 Huang MH, Li S, Hutmacher DW, Schantz JT, Vacanti CA, Braud C, Vert M. Degradation and cell culture studies on block copolymers by ring opening polymerization of ɛ-caprolactone in presence of poly(ethylene glycol). J Biomed Mater Res A 2004; 69: 417–427.
- 57 Gan Z, Liang Q, Zhang J, Iing X. Enzymatic degradation of poly(ɛ-caprolactone) film in phosphate buffer solution containing lipases. Polym Degrad Stab 1997; 56: 209–213.
- 58 Li S, Garreau H, Pauvert B, McGrath J, Toniolo A, Vert M. Enzymatic degradation of block copolymers prepared from ɛ-caprolactone and poly(ethylene glycol). Biomacromolecules 2002; 3: 525–530.
- 59 Park JS, Woo DG, Sun BK, Chung HM, Im SJ, Choi YM, Park K, Huh KM, Park KH. In vitro and in vivo test of PEG/PCL-based hydrogel scaffold for cell delivery application. J Control Release 2007; 124: 51–59.
- 60 Gong CY, Wu QJ, Dong PW, Shi S, Fu SZ, Guo G, Hu HZ, Zhao X, Wei YQ, Qian ZY. Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG–PCL–PEG hydrogel. J Biomed Mater Res B 2009; 91B: 26–36.
- 61 Yin HB, Gong CY, Shi S, Liu XY, Wei YQ, Qian ZY. Toxicity evaluation of biodegradable and thermosensitive PEG–PCL–PEG hydrogel as a potential in situ sustained ophthalmic drug delivery system. J Biomed Mater Res 2009; 92B: 129–137.
- 62
Khodaverdi E,
Golmohammadian A,
AhmadMohajeri S,
Zohuri G,
SadatMirzazadeh Tekie F,
Hadizadeh F. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) hydrogel. Int School Res Net 2012; 2012: 7. doi:10.5402/2012/976879.
10.5402/2012/976879 Google Scholar
- 63 Wang W, Deng L, Liu S, Li X, Zhao X, Hub R, Zhang J, Han H, Dong A. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(e-caprolactone) and poly(ethylene glycol)co-polymer. Acta Biomater 2012; 8: 3963–3973.
- 64 Peng CL, Shih YH, Liang KS, Chiang PF, Yeh CH, Tang IC, Yao CJ, Lee SY, Luo T-Y, Shieh MJ. Development of in situ forming thermosensitive hydrogel for radiotherapy combined with chemotherapy in a mouse model of hepatocellular carcinoma. Mol Pharm 2013; 10: 1854–1864.
- 65 Yang B, Gong CY, Qian ZY, Zhao X, Li ZY, Qi XW, Zhou ST, Zhong Q, Luo F, Wei YQ. Prevention of post-surgical abdominal adhesions by a novel biodegradable thermosensitive PECE hydrogel. BMC Biotechnol 2010; 10: 65–72.
- 66 Gao X, Deng X, Wei X, Shi H, Wang F, Ye T, Shao B, Nie W, Li Y, Luo M, Gong CY, Huang N. Novel thermosensitive hydrogel for preventing formation of abdominal adhesions. Int J Nanomed 2013; 8: 2453–2463.
- 67 Wu Q, Li L, Wang N, Gao X, Wang B, Liu X, Qian Z, Wei Y, Gong C. Biodegradable and thermosensitive micelles inhibit ischemia-induced postoperative peritoneal adhesion. Int J Nanomed 2014; 9: 727–734.
- 68 Fu SZ, Guo G, Gong CY, Zeng S, Liang H, Luo F, Zhang XN, Zhao X, Wei YQ, Qian ZY. Injectable biodegradable thermosensitive hydrogel composite for orthopedic tissue engineering. 1. Preparation and characterization of nanohydroxyapatite/poly(ethylene glycol)–poly(ɛ-caprolactone)–poly(ethylene glycol) hydrogel nanocomposites. J Phys Chem B 2009; 113: 16518–16525.
- 69 Fu S-Z, Ni P-Y, Wang B-Y, Chu B-Y, Zheng L, Luo F, Luo J-C, Qian Z-Y. Injectable and thermo-sensitive PEG–PCL–PEG copolymer/collagen/n-HA hydrogel composite for guided bone regeneration. Biomaterials 2012; 33: 4801–4809.
- 70 Ni P-Y, Fan M, Qian Z-Y, Luo J-C, Gong C-Y, Fu S-Z, Shi S, Luo F, Yang Z-M. Synthesis and characterization of injectable, thermosensitive, and biocompatible acellular bone matrix/poly(ethylene glycol)–poly (ɛ-caprolactone)–poly(ethylene glycol) hydrogel composite. J Biomed Mater Res A 2012; 100A: 171–179.
- 71 Ni PY, Ding QX, Fan M, Liao JF, Qian ZY, Luo JC, Li XQ, Luo F, Yang ZM, Wei YQ Injectable thermosensitive PEG–PCL–PEG hydrogel/acellular bone matrix composite for bone regeneration in cranial defects. Biomaterials 2014; 35: 236–248.
- 72 Manokruang K, Lee DS. Albumin-conjugated pH/thermo responsive poly(amino urethane) multiblock copolymer as an injectable hydrogel for protein delivery. Macromol Biosci 2013; 13: 1195–1203. doi:10.1002/mabi.201300236.
- 73 Houchin ML, Neuenswander SA, Topp EM. Effect of excipients on PLGA film degradation and the stability of an incorporated peptide. J Control Release 2007; 117: 413–420.
Citing Literature
